Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;12(15):1115-1119.
doi: 10.2217/imt-2020-0153. Epub 2020 Jul 9.

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology

Ting Yi Jessica Chang  1 , Janet E Pope  1   2
Affiliations
Editorial

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology

Ting Yi Jessica Chang et al. Immunotherapy. 2020 Oct.
No abstract available

Keywords: COVID-19; IL12/13; IL17; IL23; IL6 inhibitor; SARS-CoV-2; antimalarials; coronavirus; immune-mediated diseases; immunosuppressive.

PubMed Disclaimer

Comment on

References

    1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard.(2020). https://covid19.who.int/
    1. Michaud K, Wipfler K, Shaw Y. et al. Experiences of patients with rheumatic diseases in the United States during early days of the COVID-19 pandemic. ACR Open Rheumatol. 2(6), 335–343 (2020). - PMC - PubMed
    1. Emmi G, Bettiol A, Mattioli I. et al. SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun. Rev. 19(7), 102575 (2020). - PMC - PubMed
    1. Favalli EG, Agape E, Caporali R. Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis. J. Rheumatol. (2020). (Epub ahead of print). - PubMed
    1. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann. Rheum. Dis. 79(5), 667–668 (2020). - PMC - PubMed

Substances

LinkOut - more resources